$83.80-30% 1Y

Is the price fair?

Good

Cheap against its own history. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data
Vs its own P/E rangecheapest in 40 quartersderived

Cheap vs its own history: P/E 16.6 vs a 20.9 median over 40 quarters (−20% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CLX's price assumes

Clorox has no trailing P/E on file, so the price is measured against sales instead: 1.84× revenue.

1.84

Price / sales · no trailing P/E on file: measured against sales instead

EV / sales
2.27

EV / sales

Details›
EV / salesas of 2026-Q1
2.27
Market capitalisation
$11.6B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.